Headquartered in California, US, Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical and translational platforms and services to advance oncology and immuno-oncology.
We are known for our high-quality and expansive in vivo, in vitro, and ex vivo preclinical models, and partner with our clients to quantify the efficacy and pharmacological profile of their drug candidate(s) before they move into the clinic. We aim to deliver superior drug candidates to ensure that patients get the right treatment at the right time.
Crown Bioscience Inc. founded
New R&D Centre founded in Taicang, China
Crown Bioscience US R&D site founded
Acquisition of PRECOS Ltd. (Now Crown Bioscience UK)
Crown BioScience Taiwan founded
Expansion of Western PDX Models
Expansion of Western PDX Models
Acquisition of Molecular Response (Now Crown Bioscience San Diego, US)
Expansion of UK & US Oncology Facilities
Expansion of Bioinformatics Facilities, Suzhou, China
Acquisition by JSR Corporation
Expansion of China Oncology Facilities in Zhongshan
Crown Bioscience Netherlands organoid center founded
Acquisition of OcellO B.V. Expansion of in vitro capability
Crown Bioscience & MBL Joint Venture Established in Japan
Crown Bioscience Singapore founded
Acquisition of Indivumed Services
Crown Bioscience is a division of JSR Life Sciences, part of the multinational JSR Corporation.
JSR Life Sciences provides specialized technology, products, materials, and services to biopharmaceutical companies and life science researchers.
Through the service offerings of our affiliates, including Crown Bioscience, JSR has created a framework that provides a fully integrated drug development process, from discovery through commercial production, that accelerates development timelines and can increase clinical success rates.
Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical, and translational platforms to advance oncology and immuno-oncology. |
Indivumed Services is a global contract research organization (CRO) that offers an industry-leading oncology biobank and a range of service platforms to advance oncology and immuno-oncology drug discovery and development. |
MBL implements biomarker discovery for companion diagnostics, and the development and manufacturing of in vitro diagnostics (IVDS) for immunological and genetic testing. |
KBI Biopharma provides deep analytical services, process development, and GMP manufacturing for clinical trials and commercialization of biopharmaceuticals. |
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-07-11
2023-02-01
site_page